Highlights:
- SK Bioscience, the South Korean pharmaceutical company capable of producing 200 million coronavirus vaccine kits by June 2021.
- The SK Bioscience has received $3.6 million in May by the US Billionaire’s foundation to accelerate the development of the coronavirus vaccine.
- Shares of SK Chemicals, the major stakeholder in SK Bioscience, has surged by 25% on Monday.
Tags : South Korea, Vaccine, SK Bioscience, AstraZeneca, Bill Gates, COVID-19, Coronavirus,
comments (0)